Clinical Trials for Wilms Tumor and Other Childhood Kidney Tumors

2 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TherapeuticCOGADVL1121
06/13/2012
ADVL1121 - A Phase II Study of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (IND# 69896) in Children and Young Adults With Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, and Papillary Thyroid Carcinoma
TherapeuticCOGADVL0921
09/07/2011
A Phase II Study of MLN8237 (IND# 102984), a Selective Aurora A Kinase Inhibitor in Children with Recurrent/Refractory Solid Tumors and Leukemias

You do not have JavaScript enabled. This site works better with JavaScript turned on.